-
Traders Are Watching: PharmAthene (NYSEMKT:PIP), MacroGenics (NASDAQ:MGNX), MDC Partners Inc. (NASDAQ:MDCA), Foundation Medicine (NASDAQ:FMI), Balchem Corp. (NASDAQ:BCPC)
On Thursday shares of PharmAthene, Inc. (NYSEMKT:PIP) closed at $1.63. Company’s sales growth for last 5 years was -18.00%. PharmAthene, Inc. (NYSEMKT:PIP) recently announced that it has received a $5.8 million payment from Biomedical Advance Research and Development Authority (BARDA), as reconciliation between actual and provisional rates on the performance of the SparVax (an anthrax…
-
Morning Buzz: Prothena Corporation plc (NASDAQ:PRTA), Citizens Financial Group (NYSE:CFG), Foundation Medicine (NASDAQ:FMI), CEL-SCI Corporation (NYSEMKT:CVM), Celadon Group Inc. (NYSE:CGI)
On Friday shares of Prothena Corporation plc (NASDAQ:PRTA) closed at $38.66. Prothena reported promising results from an early-stage study of a drug designed to treat Parkinson’s disease. Prothena said the study showed the drug, PRX002, was safe, without serious side effects, and that it reduced levels of a protein that is believed it be associated…
-
Why These Are Hot: OncoGenex Pharmaceuticals (NASDAQ:OGXI), Aemetis (NASDAQ:AMTX), Facebook Inc (NASDAQ:FB), Liberty Tax (NASDAQ:TAX), Foundation Medicine (NASDAQ:FMI)
OncoGenex Pharmaceuticals (NASDAQ:OGXI) has signed an agreement with Teva to regain rights to custirsen, now in phase 3 development. Custirsen blocks production of the protein clusterin, which may play a role in cell survival and treatment resistance in patients with prostate and lung cancers. By inhibiting clusterin, the drug could slow tumor growth to allow…
-
5 Stock in Different Moves: LKQ Corp. (NASDAQ:LKQ), Idera Pharmaceuticals (NASDAQ:IDRA), Foundation Medicine (NASDAQ:FMI), Baxter International (NYSE:BAX), ARM Holdings (NASDAQ:ARMH)
LKQ Corporation (NASDAQ:LKQ) reported Q4 EPS of $0.26, $0.06 worse than the analyst estimate of $0.32. Revenue for the quarter came in at $1.68 billion versus the consensus estimate of $1.7 billion. LKQ Corporation sees FY2015 EPS of $1.36-$1.46, versus the consensus of $1.61. On Thursday shares of LKQ Corp. (NASDAQ:LKQ) closed at $24.78. Company’s…
-
5 Active Stocks: Parker-Hannifin Corporation (NYSE:PH), Seabridge Gold (NYSE:SA), Brookfield Asset Management Inc. (NYSE:BAM), Foundation Medicine (NASDAQ:FMI), Lattice Semiconductor (NASDAQ:LSCC)
Parker Hannifin Corporation (NYSE:PH) reported better-than-expected earnings for the fiscal second quarter and lifted its profit outlook for the year. Parker Hannifin now expects full-year earnings of $7.90 to $8.30 per share, versus its earlier forecast of $7.20 to $7.80 per share. The Cleveland, Ohio-based company posted quarterly earnings of $267.3 million, or $1.80 per…
-
Big Movers: Oncothyreon Inc (NASDAQ:ONTY), IsoRay (NYSEMKT:ISR), Foundation Medicine (NASDAQ:FMI), Mid-Con Energy Partners, LP (NASDAQ:MCEP), Hamilton Bancorp (NASDAQ:HBK)
Zacks upgraded shares of Oncothyreon (NASDAQ:ONTY) from a neutral rating to an outperform rating in a research report released on Wednesday morning. Zacks currently has $1.90 price objective on the stock. On Monday shares of Oncothyreon Inc (NASDAQ:ONTY) closed at $1.64. IsoRay Inc. (NYSEMKT: ISR) on 20 January announced that researchers at the University of…
-
Healthcare Weekly Gainers: Foundation Medicine (NASDAQ:FMI), Tekmira Pharmaceuticals Corp. (NASDAQ:TKMR), ZIOPHARM Oncology (NASDAQ:ZIOP), Pharmacyclics Inc. (NASDAQ:PCYC), DepoMed Inc. (NASDAQ:DEPO)
Foundation Medicine, Inc. (NASDAQ:FMI) and Roche announced on 12 January that they will enter into a broad strategic collaboration to further advance Foundation Medicine’s market-leading position in molecular information and genomic analysis while providing Roche a unique opportunity to optimize the identification and development of novel treatment options for cancer patients. On Friday shares of…
-
5 Stocks in Dramatic Moves: Petroleo Brasileiro Petrobras (NYSE:PBR), Foundation Medicine (NASDAQ:FMI), Parke Bancorp Inc. (NASDAQ:PKBK), StanCorp Financial (NYSE:SFG), Intuitive Surgical (NASDAQ:ISRG)
Shares of Petroleo Brasileiro Petrobras SA (NYSE:PBR) have earned an average rating of “Hold” from the eleven brokerages that are covering the stock, AnalystRatingsNetwork reports. One equities research analyst has rated the stock with a sell recommendation, six have assigned a hold recommendation and three have assigned a buy recommendation to the company. On Monday…
-
Healthcare Stocks Touched New Highs: IRadimed Corporation (NASDAQ:IRMD), Foundation Medicine (NASDAQ:FMI), SCYNEXIS (NASDAQ:SCYX), Advaxis (NASDAQ:ADXS), Agenus Inc. (NASDAQ:AGEN)
Iradimed Corp (NASDAQ:IRMD) VP Steven M. Nardi acquired 2,100 shares of Iradimed Corp stock on the open market in a transaction dated Monday, December 29th. The stock was purchased at an average price of $12.58 per share, for a total transaction of $26,418.00. Following the completion of the transaction, the vice president now directly owns…